| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |